About 670 results

ALLMedicine™ Sinus Bradycardia Center

Research & Reviews  218 results

The cardiovascular effects of amodiaquine and structurally related antimalarials: An in...
PLoS Medicine; Chan XHS, Haeusler IL et. al.

Sep 8th, 2021 - Amodiaquine is a 4-aminoquinoline antimalarial similar to chloroquine that is used extensively for the treatment and prevention of malaria. Data on the cardiovascular effects of amodiaquine are scarce, although transient effects on cardiac electro...

23-year-old woman • syncopal episode • sinus bradycardia • history of bipolar disorder ...
The Journal of Family Practice; Fletke K, Blanchard J et. al.

Jul 28th, 2021 - ► Syncopal episode ► Sinus bradycardia ► History of bipolar disorder.

Sinus Bradycardia in Children Treated With Remdesivir for COVID-19.
The Pediatric Infectious Disease Journal; Eleftheriou I, Liaska M et. al.

Jul 22nd, 2021 - Sinus Bradycardia in Children Treated With Remdesivir for COVID-19.|2021|Eleftheriou I,Liaska M,Krepis P,Dasoula F,Dimopoulou D,|

Pulmonary Vein Isolation and Pacemaker Implantation in a Patient with Dextrocardia Situ...
International Heart Journal; Yokoyama Y, Aiba T et. al.

Jul 20th, 2021 - A 70-year-old female with dextrocardia with situs inversus (DSI) totalis and inferior vena cava occlusion underwent radiofrequency catheter ablation because she had symptomatic paroxysmal atrial fibrillation (AF). Careful preoperative examination ...

Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 Pneumonia W...
Southern Medical Journal; Stancampiano F, Omer M et. al.

Jul 4th, 2021 - To assess the clinical characteristics and clinical outcomes of bradycardic patients with coronavirus disease 2019 (COVID-19) pneumonia. The electronic medical records of 221 consecutive patients hospitalized for COVID-19 pneumonia between June an...

see more →

Drugs  19 results see all →

News  31 results

Remdesivir Safe in COVID-19 Patients, Despite Risk of Sinus Bradycardia

Jul 15th, 2021 - NEW YORK (Reuters Health) - Remdesivir treatment of lower respiratory infection in hospitalized patients with COVID-19 appears safe, even though some patients develop sinus bradycardia, a single-center prospective study from Italy suggests. "Cardi...

EMA Says Sinus Bradycardia a Possible Risk With Remdesivir

Jun 11th, 2021 - Following a safety review, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has recommended adding sinus bradycardia to the product label for remdesivir (Veklury) as an adverse reaction of "unknown freq...

Remdesivir Not Linked to Kidney Injury, EU Investigating for Sinus Bradycardia

Feb 16th, 2021 - Remdesivir (Veklury) is not associated with acute kidney injury, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has concluded following a safety review. Remdesivir currently has conditional marketing ...

ECG Challenge: Runner With an Irregular Beat

Jul 1st, 2019 - The correct diagnosis is sinus bradycardia, interpolated junctional premature complexes in a trigeminal pattern, and retrograde concealed conduction. Figure 2. Courtesy of Dr Podrid Discussion The rhythm is irregular, but there is a pattern. All o...

When Life Leaves You Breathless
Lyle W. Larson, PhD, PA-C

Aug 8th, 2018 - ANSWER The correct interpretation includes marked sinus bradycardia with sinus arrhythmia, biatrial enlargement, and an RSR’ pattern in lead V1 suggestive of right ventricular conduction delay. A heart rate below 60 beats/min is considered sinus b.

see more →